HomeMy WebLinkAbout173-20 RESOLUTION113 West Mountain Street
Fayetteville, AR 72701
(479) 575-8323
Resolution: 173-20
File Number: 2020-0526
ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION
OF CITY HEALTH OFFICER:
A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE
POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE
AMOUNT OF $50,000.00
WHEREAS, Ark. Code Ann. § 14-262-102 authorizes the City to establish a board of health and to "invest
the board with such powers and impose upon it such duties as shall be necessary to secure the city
and its inhabitants from the evils of contagious, malignant, and infectious diseases"; and
WHEREAS, Ark. Code Ann. § 14-262-103 authorizes the City to create the position of City Health Officer
with the powers and duties set forth in that statute; and
WHEREAS, pursuant to Ark. Code Ann. § 14-262-116(b)(12) and § 14-262-115(a)(4), a city board of health
is empowered "to adopt such rules and regulations, not inconsistent with the public health laws of this state
nor with the orders and rules of the State Board of Health"; and
WHEREAS, the significant rise in COVID-19 cases justifies the reinstitution of the City Board of Health
and the re-establishment of the position of City Health Officer to assist the City with its response to the
pandemic.
NOW, THEREFORE, BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF
FAYETTEVILLE, ARKANSAS:
Section 1: That the City Council of the City of Fayetteville, Arkansas hereby creates the City Board of
Health which shall consist of five members appointed by the Mayor, at least two of whom shall be physicians
of good professional standing. The initial members shall serve for the following terms: one
Page 1 Printed on 6/M0
Resolution: 173-20
File Number. 2020-0526
shall serve for one (1) year, one for two (2) years, one for three (3) years, one for four (4) years, and
one for five (5) years, from January 1 of the year appointed; thereafter, full -tern appointments shall be
for five (5) years. In addition to the Mayor and up to one city employee, the Mayor may appoint up to
two ex-officio members who shall serve during the Mayor's tern of office.
The City Board of Health shall have those powers and duties conferred by Ark. Code Ann. § 14-262-
102 including such powers as are necessary to secure the city and its inhabitants from the evils of
contagious, malignant, and infectious diseases. The City Board of Health shall develop a job description
for the City Health Officer and submit nominations for that office to the Mayor when a vacancy occurs. The
City Board of Health shall submit nominations for the ex-officio members to the Mayor at the
beginning of the Mayor's term of office and shall include residents with expertise and credentials relevant to
pressing public health issues affecting the jurisdiction of the City Board of Health. The City Board of
Health shall promulgate rules and regulations necessary for the conduct of its meetings, including the
election of officers, and for carrying out its statutory powers and duties, not inconsistent with the public
health laws of this state nor with the orders and rules of the State Board of Health.
Section 2: That the City Council of the City of Fayetteville, Arkansas hereby establishes the office of
City Health Officer, who shall be a competent physician of reputable professional standing who is legally
qualified to practice medicine in Arkansas. The City Health Officer shall be appointed by the Mayor
and approved by the City Council. The City Health Officer shall have those powers and duties
conferred by state law or city ordinance or resolution, but shall not be required to treat patients, prescribe
medicine, or do anything else not statutorily required pursuant to Ark. Code Ann. § 14-262-103.
Section 3: The City Council of the City of Fayetteville, Arkansas hereby determines that this Resolution
should be reviewed within four weeks of the end of any relevant state of emergency to determine whether
the City Board of Health should be dissolved, reconstituted, or repurposed. When such a state of
emergency ends, the City Board of Health should provide a summary list, with annotations, of pressing
public health issues.
Section 4: That the City Council of the City of Fayetteville, Arkansas hereby approves a budget
adjustment in the amount of $50,000.00 for staffing, supplies, and other needs of the City Health Officer
and the City Board of Health in the course of their work.
PASSED and APPROVED on 6/24/2020
Page 2 Printed on 6124120
Resolution: 173-20
File Number: 2020-0526
Page 3
Attest:
1111
,,y GLE R X f
. • �F ��
• FgYE •�.
Kara Paxton. City Clerk Treasurc-r �FVj��e : rn_
•,v
iidiiiilikO,�
Printed on 6124120
City of Fayetteville, Arkansas 113 West Mountain Street
• Fayetteville, AR 72701
(479) 575-8323
Text File
�= File Number: 2020-0526
Agenda Date: 6/24/2020 Version: 1 Status: Passed
In Control: City Council Meeting
Aqenda Number: A 1
File Type: Resolution
ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE POSITION OF CITY
HEALTH OFFICER:
A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH AND THE
POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET ADJUSTMENT IN THE
AMOUNT OF $50,000.00
WHEREAS, Ark. Code Ann. § 14-262-102 authorizes the City to establish a board of health and to "invest
the board with such powers and impose upon it such duties as shall be necessary to ... secure the city and its
inhabitants from the evils of contagious, malignant, and infectious diseases"; and
WHEREAS, Ark. Code Ann. § 14-262-103 authorizes the City to create the position of City Health Officer
with the powers and duties set forth in that statute; and
WHEREAS, pursuant to Ark. Code Ann. § 14-262-116(b)(12) and § 14-262-115(a)(4), a city board of
health is empowered "to adopt such rules and regulations, not inconsistent with the public health laws of this
state nor with the orders and rules of the State Board of Health"; and
WHEREAS, the significant rise in COVID-19 cases justifies the reinstitution of the City Board of Health and
the re-establishment of the position of City Health Officer to assist the City with its response to the pandemic.
NOW, THEREFORE, BE IT RESOLVED BY THE CITY COUNCIL OF THE CITY OF
FAYETTEVILLE, ARKANSAS:
Section 1: That the City Council of the City of Fayetteville, Arkansas hereby creates the City Board of Health
which shall consist of five members appointed by the Mayor, at least two of whom shall be physicians of good
professional standing. The initial members shall serve for the following terms: one shall serve for one (1) year,
one for two (2) years, one for three (3) years, one for four (4) years, and one for five (5) years, from January 1
of the year appointed; thereafter, full -term appointments shall be for five (5) years. In addition to the Mayor and
up to one city employee, the Mayor may appoint up to two ex-officio members who shall serve during the
Mayor's term of office.
The City Board of Health shall have those powers and duties conferred by Ark. Code Ann. § 14-262-102
including such powers as are necessary to secure the city and its inhabitants from the evils of contagious,
malignant, and infectious diseases. The City Board of Health shall develop a job description for the City Health
City of Fayetteville, Arkansas Page 1 Printed on 6/24/2020
File Number 2020-0526
Officer and submit nominations for that office to the Mayor when a vacancy occurs. The City Board of Health
shall submit nominations for the ex-officio members to the Mayor at the beginning of the Mayor's term of office
and shall include residents with expertise and credentials relevant to pressing public health issues affecting the
jurisdiction of the City Board of Health. The City Board of Health shall promulgate rules and regulations
necessary for the conduct of its meetings, including the election of officers, and for carrying out its statutory
powers and duties, not inconsistent with the public health laws of this state nor with the orders and rules of the
State Board of Health.
Section 2: That the City Council of the City of Fayetteville, Arkansas hereby establishes the office of City
Health Officer, who shall be a competent physician of reputable professional standing who is legally qualified to
practice medicine in Arkansas. The City Health Officer shall be appointed by the Mayor and approved by the
City Council. The City Health Officer shall have those powers and duties conferred by state law or city
ordinance or resolution, but shall not be required to treat patients, prescribe medicine, or do anything else not
statutorily required pursuant to Ark. Code Ann. § 14-262-103.
Section 3: The City Council of the City of Fayetteville, Arkansas hereby determines that this Resolution should
be reviewed within four weeks of the end of any relevant state of emergency to determine whether the City
Board of Health should be dissolved, reconstituted, or repurposed. When such a state of emergency ends, the
City Board of Health should provide a summary list, with annotations, of pressing public health issues.
Section 4: That the City Council of the City of Fayetteville, Arkansas hereby approves a budget adjustment in
the amount of $50,000.00 for staffing, supplies, and other needs of the City Health Officer and the City Board
of Health in the course of their work.
City of Fayetteville, Arkansas Page 2 Printed on 612412020
Legistar ID No.: 2020-0526
AGENDA REQUEST FORM
FOR: Special City Council Meeting of June 24, 2020
FROM: Mayor Lioneld Jordan
Council Member Matthew Petty
ORDINANCE OR RESOLUTION TITLE AND SUBJECT:
A RESOLUTION TO ESTABLISH THE FAYETTEVILLE CITY BOARD OF HEALTH
AND THE POSITION OF CITY HEALTH OFFICER, AND TO APPROVE A BUDGET
ADJUSTMENT IN THE AMOUNT OF $50,000.00
ENDA:
,//, /j z i /j 6,
Council Member Matthew Petty Date
N I N �UZ,D
Assistant City Attorney Blake Pennington Date
Approved as to form
Pennington, Blake
From:
Matthew Petty - Fayetteville Ward 2 <citycouncil@matthewpetty.org>
Sent:
Wednesday, June 24, 2020 9:02 AM
To:
Pennington, Blake
Cc:
Mayor; Norton, Susan
Subject:
Re: Agenda Request Form
CAUTION: This email originated from outside of the City of Fayetteville. Do not click links or open attachments unless you recognize
the sender and know the content is safe.
Confirmed. Thank you.
I will transmit final materials for the packet within the hour
On Wed, Jun 24, 2020, 8:32 AM Pennington, Blake <bpennington@favetteville-ar.gov> wrote:
I have heard there will be a special city council meeting this evening to discuss the board of health resolution. I am
attaching a revised agenda request form to reflect the date change. Matthew, if you will confirm you are requesting
this item be added to the agenda for the special meeting today that will be sufficient.
Blake
Blake E. Pennington
Assistant City Attorney
113 W. Mountain St., Suite 302
Fayetteville, Arkansas 72701
Telephone: (479) 575-8313
bpennington@fayetteville-ar.gov<mailto:bpennington@favetteville-ar.gov>
[City attorney logo]<http://www.favetteville-ar.gov/492/City-Attorney>[cid:image002.jpg@OlD287AB.2928ClEO]
<http://www.fayetteville-ar.gov/>
Facebook<https://www.facebook.com/fayetteviIlearkansasgovernment> I Twitter<https://twitter.com/fyvgov>
Instagram<https://www.instagram.com/fyvgov/> I YouTube<http://www.youtube.com/user/cityoffayetteviIlear>
CITY OF
Tay% e eVl e
ARKANSAS
TO: City Council
Mayor
FROM: Matthew Petty, Councilmember
Susan Norton, Chief of Staff
DATE: June 23, 2020
SUBJECT: A resolution to reconstitute a Fayetteville Board of Health
MEMO
Background
In Arkansas, cities can create a Board of Health. State law § 14-262-102 and other related
statutes give a Board of Health important powers during epidemics. The City of Fayetteville
repealed its Board of Health less than two years ago due to lack of business. The proposal is to
reconstitute the Board as an independent body whose purpose is primarily advisory with respect
to relevant governmental units (see Duties in the included prospective agenda). Other duties
may be taken up by the Board if the Board judges those duties to be necessary for the public
health and in accordance with relevant ordinances, statutes, and guidelines.
Timeline
First meeting: As soon as possible, subject to Board availability.
Subsequent meetings: Loosely speaking, every two weeks during an epidemic.
City Health Officer
State law also provides for cities to appoint a City Health Officer with certain duties. The
proposal is for the position to be created and funded by the city in coordination with the new
Board's advice.
Funding
Another component of the proposal is a budget adjustment of $50,000 in emergency funding to
support the Board and City Health Officer in the execution of their duties.
Positions
State statute sets the formal membership of the Board at five members, two of whom must be
physicians. This proposal is to extend that membership with ex-officio positions as may be
judged necessary by the Mayor and as advised by the Board of Health. Ex-officio positions are
intended to be occupied by qualified individuals with credentials relevant to pressing public
health conditions.
The proposal recommends filling the new Board with the following positions:
1. Officer or director of city's largest medical research institution
2. Officer or director city's largest hospital system
Mailing Address:
113 W. Mountain Street www.fayetteville-ar.gov
Fayetteville, AR 72701
3. Current or former university clinic director/manager
4. Current or former multi -site clinic director/manager
5. Current or former director/manager of a psychiatric clinic or social services provider
• Ex-officio, at -large with relevant credentials
• Ex-officio, at -large with relevant credentials
• Ex-officio, city public safety director as designated by the Mayor
• Ex-officio, Mayor
Prospective members
1. Jay Gandy, PhD. Associate Provost, UAMS Northwest.
2. Lenny Whiteman. Vice President of Managed Care, Washington Regional.
3. Huda Sharaf, MD. Medical Director, Pat Walker Health Center.
4. Gary Berner, MD. Chief Medical Officer, Community Clinic.
5. Joey Gardner, DSW. Care Coordinator Supervisor, Beacon Health Operations.
• Stephanie Ho, MD. Physician, Vector Health and Wellness.
• Hershey Garner, JD MD. Physician, Highlands Oncology Group.
• Brad Hardin. Fire Chief, City of Fayetteville.
• Lioneld Jordan. Mayor, City of Fayetteville.
Prospective First Agenda
The proposal also suggests a first agenda for the new Board. While the Board is independent
and will set its own agenda, this agenda is presented as a guide for the new Board to use in
their first meeting.
Election of a chairperson and summary bylaws
The Chairperson shall preside over the meetings and serve as the primary point of contact with
the City and/or a City Health Officer.
1. Chair calls meetings and presides over them.
2. Chair sets meeting agendas.
3. Chair executes Board decisions; city assists and collaborates.
4. Rules and roles may change when a City Health Officer is appointed.
Summary jurisdiction and powers
Board has jurisdiction for one mile beyond the city limits, or five miles beyond the city limits
during an epidemic, by state statute. The Board has the power to assess and advise, and to
issue from time to time such orders and to adopt such rules and regulations, not inconsistent
with the public health laws of this state nor with the orders and rules of the State Board of
Health, as the Board may deem necessary for the proper exercise of its powers and duties.
Refer to the enabling statute for a full description of the jurisdiction and powers.
Summary purpose
The intended purpose is to advise relevant governmental units of the state of health of the
population within the statutory jurisdiction of the Board, including with respect to declared public
health emergencies. The Fayetteville City Council has directed the Board to focus on the
COVID-19 infectious disease epidemic. Refer to enabling statutes for a complete description of
the purpose.
Sunset
The City Council is required to consider the Board's dissolution, reconstitution, and/or
repurposing within four weeks of the end of any relevant state of emergency. When such a state
of emergency ends, the Board should provide a summary list, with annotations, of pressing
public health issues.
Duties
1. Advise relevant governmental units as to the following:
a. Public health threats, including infectious disease epidemics, and opportunities
for coordinated mitigation
b. Strategies, metrics, and benchmarks with respect to governmental public health
campaigns, specifically with respect to
i. Increasing adoption of advised personal health practices in the household
and the workplace
ii. Increasing voluntary compliance with public health advisories
iii. Increasing understanding of public health best practices and policies
1. Specifically including but not limited to, increasing voluntary
compliance of mask -wearing advisories
2. Make reports of the Board's meetings available to relevant governmental units.
Independence of the Board
1. The Board sets its own agendas.
2. The Board is intended to be an agent for the public health itself and not be beholden to
any particular political interest.
3. All advice provided by the Board should be based on empirical evidence to the greatest
extent possible.
Vote: Resolution affirming the City of Fayetteville is in a state of epidemic
Sample resolution text, to be amended at the Board's discretion:
On the basis of the best epidemiological reporting and analysis available to the
Fayetteville Board of Health and in accordance with all relevant ordinances and statutes,
the Board hereby affirms there is an infectious disease epidemic within its jurisdiction.
City report on communication with state officials
The City will provide a short briefing (ten minutes).
Vote: Resolution advising the epidemiological necessity of Fayetteville's mask law
Sample resolution text, to be amended at the Board's discretion:
On the basis of the best epidemiological reporting and analysis available to the
Fayetteville Board of Health, the Board hereby advises Ordinance 6323, colloquially
known as the Fayetteville Mask Ordinance and which establishes a mask requirement,
reasonable exemptions, and a public health campaign, is necessary to meet the
community's COVID-19 management targets and protect the health, safety, and welfare
of its inhabitants.
Feedback on city report on public outreach and education
The city will provide a short briefing (ten minutes) to the Board on efforts to promote mask -
wearing and other practices which reduce the spread of COVID-19. The Board is asked to
provide feedback to the City to maximize the impact of the City's resources. The City has
currently budgeted $100,000 for this effort.
Vote: Resolution requesting state COVID-19 press conference in Fayetteville
Sample resolution text, to be amended at the Board's discretion:
In consideration of the state of epidemic in the City of Fayetteville and Governor Asa
Hutchinson's call for a coordinated response with local cities, the Fayetteville Board of
Health respectfully requests the daily Arkansas COVID-19 press conference be held in
Fayetteville in approximately two weeks and that attending state officials meet with
relevant institutions and leaders at that time.
Preliminary discussion of City Health Officer position
The Board is requested to provide a shortlist to the Mayor to fill this position. The City will
provide a short briefing (five minutes) to the Board about the role of this position with respect to
the municipal apparatus. The Board is invited to discuss the potential of this position and to
assist with the creation of a job description, including how an interim function may be served by
a Board member, city staff, or other qualified individual. City funding has been made available to
meet these needs.
Set next meeting
Adjourn
CURRICULUM VITAE
Jay Gandy, Ph.D.
Associate Provost
University of Arkansas for Medical Sciences, Northwest
1125 N. College Ave. Work phone: 479-713-8125
Fayetteville, AR 72703 e-mail: jgandy(d)uams.edu
Date of Birth: January 15, 1954
Place of Birth: Memphis, TN
411LOYM 191j
Ph.D. 1985 University of California, Riverside (Field of Study - Toxicology)
M.S. 1982 University of California, Davis (Field of Study - Neurotoxicology)
B.S.A. 1976 University of Arkansas - (Entomology - with High Honors)
AiFiI2XGYJ Jj1:4Zk 6
2019-present Associate Provost
University of Arkansas for Medical Sciences, Northwest
Arkansas Campus
2019 Interim Dean
Fay W. Boozman College of Public Health
University of Arkansas for Medical Sciences (UAMS)
2001-present Professor
Dept. of Environmental and Occupational Health
Fay W. Boozman College of Public Health
University of Arkansas for Medical Sciences
2001 -April 2020 Chair
Dept. of Environmental and Occupational Health
Fay W. Boozman College of Public Health
University of Arkansas for Medical Sciences
1997-2010 Principal Toxicologist and Founding Partner
Center for Toxicology & Environmental Health, L.L.C.
2010-Present Director, Regulatory Sciences Program,
UAMS Graduate School
1996-2012 Director, Occupational & Environmental Health M.S. Program
UAMS Graduate School
1991-2007 Associate Professor
Dept. of Pharmacology & Toxicology, College of Medicine
UAMS
1992 AAAS/EPA Environmental Fellow
Office of Research and Development
06/22/20
U.S. Environmental Protection Agency
Washington, D.C.
1991 Visiting Associate Professor
Division of Medical Toxicology, College of Medicine
Univ. of Colorado Health Sciences Center
1986-1991 Assistant Professor
Dept. of Pharmacology & Toxicology, College of Medicine
UAMS
1985-1986 Instructor in Toxicology
Dept of Pharmacology & Toxicology, College of Medicine
UAMS
PROFESSIONAL SOCIETIES:
Society of Toxicology
South Central Chapter Society of Toxicology
American Chemical Society
American Conference of Governmental Industrial Hygienists
Delta Omega (Honary Society in Public Health)
EDITORIAL BOARDS OF PEER REVIEWED JOURNALS:
Toxicological Sciences (1999-2002)
Toxicology Letters (1996-2000)
Fundamental and Applied Toxicology (1995-1998)
GRANTS AND CONTRACTS:
NIH: NIOSH. Epididymal GSH in chemical -induced germ cell mutations. Award
period: May 1986-April 1988. Role: Principal Investigator.
NIH: National Institute of Occupational Safety and Health. Epididymal GSH in
chemical -induced germ cell mutations. Award period: May 1986-April 1988;
Role: Principal Investigator
NIH: National Institute of Environmental Health Sciences. Role of glutathione in
male reproductive toxicity. Award period: July 1989-June 1994; Role: Principal
Investigator
NIH: National Institute of Environmental Health Sciences. Immunotoxicity of propanil
and tetrachloroazobenzene. Award Period: January 1989-December 1994;
Role: Co -Investigator
06/22/20
American Institute for Cancer Research. Effects of caloric restriction on rat
testicular tumor formation. Award Period: January 1993-December 1994; Role:
Principal Investigator
U.S. Environmental Protection Agency. Arkansas Clinical and Developmental
Toxicology Program. Award period (Tom Badger, PI): July 1994-June 1996;
Role: Program Manager
Program Project: Evaluation of the immunotoxic properties of the herbicide,
propanil, in families. Role: Principal Investigator
Program Project: Establishment of a Toxicant Exposure Registry in Arkansas.
Role: Principal Investigator
U.S. Environmental Protection Agency. Improved reproductive risk assessment by
elucidation of metabolic functions. January 2000-December 2001. Role:
Principal Investigator
NIH: National Institute of Child Health and Human Development. National
Children's Study — Arkansas Study Center (Charolett Hobbs, PI), October 2008-
October 2011. Role: Co -Investigator
U.S. Environmental Protection Agency. Integrated Science Assessment for Lead
Toxicity: Evidence of Reproductive and Developmental Effects of Lead. Contract
Period: August 2010-June 2011. Role: Document Author.
U.S. Environmental Protection Agency Human Health Risk Assessment. Integrated
Science Assessment for Particulate Matter. Contract Period: May 2015-April
2016. Role: Section Author.
GOVERNMENTAL ADVISORY POSITIONS:
Pesticide toxicology consultant for EPA Technical Assistance Team at the Minot,
ND pesticide warehouse fire. 1987.
Arkansas Department of Health - Environmental Health Conferences: Exposure to
Hazardous Substances in Arkansas. Presentations to Arkansas physicians at
AHEC Centers on health effects of pesticide exposures. 1989-1991
U.S. Food and Drug Administration - Lecturer on chemical classes and toxicities of
pesticides for FDA state health departments training courses entitled "Pesticides
and Industrial Chemicals" - Training course presented in Little Rock, AR, Seattle,
WA, Princeton, NJ, Minneapolis, MN and Denver, CO. 1990-1992
U.S. Food and Drug Administration - Lecturer on the interactions of science and law
for FDA state health departments training courses entitled, "Legal Aspects of
Enforcement"; presented in Harrisburg, PA. Weston, W. VA, Little Rock, AR,
Phoenix, AZ, Louisville, KY, and Jackson, MS. 1987-1990
Consideration of different risk assessment approaches for male reproductive
toxicities. Prepared for the U.S. Environmental Protection Agency, 1992.
Consultation to the Arkansas Dept. of Health and the Ark. State Plant Board
regarding health effects of Command herbicide drift, 1993.
06/22/20
Testimony before the Arkansas General Assembly Joint Committee on Public
Health, Welfare & Labor - Investigation of health risks related to Command
herbicide, 1993.
Consultation to the Arkansas Dept. of Health and the Ark. State Plant Board
regarding health effects of herbicide groundwater contamination, 1994.
U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1995.
NIH National Center for Research Resources Site -visit Review Committee, 1995.
U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1996.
NIH National Center for Research Resources Initial Review Group, 1996.
National Center for Toxicological Research, Toxicology Study Section and Review
Committee (Endocrine disruptors), U.S. Food & Drug Administration, 1996-
1998.
U.S. Environmental Protection Agency Fellowship Grant Review Panel, 1997.
U.S. Environmental Protection Agency's Health -Related Life Sciences Peer Review
Panel, 1997.
NIH National Toxicology Program External Scientific Reviewer, 1997-2000.
Consultation to the Arkansas Dept. of Health regarding potential health effects
associated with trace dioxin levels in chicken, eggs, and catfish, 1997.
U.S. Environmental Protection Agency — Animal Testing External Peer Reviewer,
1997.
U.S. Environmental Protection Agency — Peer review of reference dose (RfD)
determination for reproductive studies of chlorite, 1998.
Arkansas Department of Health Expert Panel Selection and Planning Committee,
1998.
Contractor to Arkansas Department of Health - provide technical assistance in the
performance of a cooperative agreement with the Department of Army regarding
activities related to Chemical Demilitarization Project at the Pine Bluff Arsenal,
1997-98.
U.S. Environmental Protection Agency Grant Peer Review Panel — Interindividual
variation in human susceptibility to environmentally -caused disease, 1998.
U.S. Environmental Protection Agency Reference Dose Peer Review Panel — IRIS
Toxicological Review for Vinyl Chloride. 1999.
Peer reviewer for DOD/VA Health Research Program, US Army Medical Research
and Material Command, 1999.
06/22/20
Grant reviewer for NIOSH Southwest Center for Occupational and Environmental
Health, Univ. of Texas, 2000.
Interagency Coordinating Committee on the Validation of Alternative Methods/
National Toxicology Program - Expert Panel to assess validation status and
usefulness of FETAX assay for regulatory purposes, 2000.
CDC National Institute for Occupational Safety and Health Special Emphasis RFA
Peer Review Panel, 2000.
Arkansas Department of Health Search Committee for Director of Epidemilogy,
2000-01.
Arkansas Department of Health: Consultant to Public Health Laboratory
Biomonitoring Planning Grant, 2001-2003.
U.S. Environmental Protection Agency External Peer Review of oral two -generation
reproduction study of dibromoactic acid, 2002.
Assocition of Schools of Public Health/CDC Global Health Fellowship Reviewer, 2008
EPA/ASPH Environmental Health Fellowship Program Reviewer, 2009.
U.S. EPA Integrated Science Assessment for Lead, Consultant/Section Author for
Toxicological Evidence of Reproductive and Developmental Effects of Lead
Section, 2011.
U.S. EPA Draft Drinking Water Health Advisory for 1,3-dichloropropene and
Summary from the Advisory for 1,3-Dichloropropene, External Peer Reviewer,
2012.
Science Advisory Board, National Center for Toxicological Research, U.S. Food and
Drug Administration. 2012-2016.
Science Advisory Board Subcommittee Review of FDA NCTR Division of
Microbiology, Committee Co -Chair. July 2013.
Science Advisory Board Subcommittee External Review of FDA NCTR Division of
Biochemical Toxicology, Committee Co -Chair. November 2014.
U.S. EPA Integrated Science Assessment for Particulate Matter, Consultant/Section
Author for Toxicological Evidence of Reproductive and Developmental Effects,
2015-2016.
U.S. EPA External Peer Review of the Draft Provisional Peer -Reviewed Toxicity
Value (PPRTV) document for 1,1,2-Trichloro-1,2,2-Trifluoroethane, 2016
Arkansas Reproductive Health Comitoring System Advisory Commission, 2016-
2018.
U.S. EPA External Letter Peer Review of a Study Report on 1,3,5-trinitro-1,3,5-
hexahydrotriazine (RDX) Performed by Midwest Research Institute (Cholakis et
al., 1980). 2017.
06/22/20
U.S. EPA External Peer Review of Two Laboratory Reports on Chloroform in Wistar
Rats Performed by Hoechst Aktiengesellschaft, 2018.
PROFESSIONAL SERVICE:
Councilor (Immediate -Past President) - South Central Chapter of the Society of
Toxicology, 1997-98
President - South Central Chapter of the Society of Toxicology, 1996-97
President -Elect - South Central Chapter of the Society of Toxicology, 1995-96
Vice -President - South Central Chapter of the Society of Toxicology, 1994-95
Counselor - South Central Chapter of the Society of Toxicology, 1992-94
SIGNIFICANT UNIVERSITY SERVICE AND COMMITTEES
Institutional Animal Care and Use Committee. 1985-1987
LCME Accreditation Self -study Subcommittee for Department of Biochemistry
evaluation. 1991
Chair, Biomedical Research Center Facilities Management Committee. 1994-96
Graduate Council, Interdisciplinary Toxicology Representative. 1994-1998
Graduate Council Subcommittee on Faculty
Graduate Council, Occupational & Environmental Health Representative. 1998-
2002
Graduate Council Subcommittee on Faculty
Institutional Copyright Guidelines Committee (College of Medicine representative).
1998-2000
College of Public Health Planning Committee, (COPH) Curriculum Subcommittee.
2000-2001
Search Committee for Dean, College of Public Health. 2002
COPH Dean's Executive Committee, 2004-present
COPH Appointment, Promotion, and Tenure Committee. 2003-2006; 2019-present
COPH Appointment, Promotion, and Tenure Committee, Chair - 2006-2018
COPH Faculty Incentive Plan Committee. 2010
BioVentures Business Accelerator Advisory Board. 2009-2016
Program Director— Regulatory Sciences Program 2011-present
Search Committee Chair: Department of Health Policy and Management Chair — 2013
Working Group on Facutly Performance Excellence, 2014
Search Committee Chair: Department of Epidemiology Chair — 2015
UAMS Patent and Copyright Committee, 2017-present
Search Committee Chair: Dean, College of Public Health 2018-2019
Search Committee Chair: Vice Chancellor for Human Relations, 2019
Search Committee Chair: Associate Provost for Faculty & Continuing Education, 2020
UAMS laison to UAF-UAMS Research Collaborative, 2000: Pilot Study Funding
Committee Chair; Intercampus Transportation Committee Chair; Smooth Funding
Intrastructure Subcommittee Co-chair; Logistics, Policy and Process
Subcommittee Co-chair.
UAMS-UAF Joint MD/MBA Program Committee, 2020
06/22/20
TEACHING EXPERIENCE:
Toxicology for Graduate Students (Pulmonary tox. & Repro. tox. lectures) 1986-2004
General Principles of Pharmacology and Toxicology (Drug metabolism & Risk assess.
lectures) 1992-2007
Advanced Toxicology (Pesticides, silicones, asbestos, silica, phthalates, risk
assessment lectures) 1987-2005; Course director 1989-2000
Government Regulations in Toxicology, (Course Director 1985-2005)
Emergency Medicine Residency Program - Pesticide toxicities, 1990
Medical Pharmacology (General principles of toxicology and pesticide lectures to
medical students) 1994-2002, 2006.
Co -leader small group case conferences 1994-1996
Community Health Nursing (Toxicology & Environmental Health lectures) 1994-2016
UALR Law School, Environmental Law (Principles of toxicology and risk assessment
lecture) 1994
Family and Community Health Practice Residency Program - General Priniples of
Toxicology and Causation Analysis, 1996
Government Regulations in Public Health 2009-2011, 2013-present
Clinical Toxicology (Dept. Pharmacology & Toxicology: Pesticide lecture) 2009-2015
Introduction to Public Health (Intro to Environmental & Occ. Health lecture) 2005-
2010
Environmental Health Policy 2010-2012
Principles of Food and Drug Regulations 2012 - 2018
PUBLICATIONS:
Imamura, T., J. Gandy, T.R. Fukuto and P. Talbot. 1983. An impurity of malathion
alters the morphology of rat lung bronchiolar epithelium. Toxicology 26:73-79.
2. Imamura, T., L. Hasegawa, J. Gandy and T.R. Fukuto. 1983. Effect of drug
metabolism inducer and inhibitor on O,O,S-trimethyl phosphorothioate-induced
delayed toxicity in rats. Chemico.-Biol. Interact., 45:53-64.
3. Imamura, T., J. Gandy and T.R. Fukuto. 1983. Selective inhibition of rat pulmonary
monooxygenase by O,O,S-trimethyl phosphorothioate treatment. Biochem.
Pharmacol. 32:3191-3195.
4. Gandy, J., P. Talbot, T.R. Fukuto and T. Imamura. 1983. Phenobarbital
pretreament protects against morphological changes in rat bronchiolar epithelium
caused by an impurity of malathion. Amer. J. Pathol. 111:350-353.
5. Gandy, J., T.R. Fukuto and T. Imamura. 1984. Sequential and dose -dependent
morphological alterations in the rat bronchiolar epithelium during O,O,S-trimethyl
phosphorothioate induced delayed toxicity. J. Pathol. 143:127-137.
6. Gandy, J., F.A.F. Ali, L. Hasegawa and T. Imamura. 1984. Morphological
alteration of rat lung bronchiolar epithelium produced by various trialkyl
phosphorothioates. Toxicology 32:37-46.
7. Imamura, T., J. Gandy and L, Hasegawa. 1985. Development of tolerance to a
pneumotoxic impurity of malathion. J. Toxicol. Environ. Health., 15:279-291.
06/22/20
8. Gandy, J. and T. Imamura. 1985. Cellular responses to O,O,S-trimethyl
phosphorothioate-induced pulmonary injury in rats. Toxicol. Appl. Pharmacol.,
80:51-57
9. Gandy, J., C.M. Teaf, F.A. Adatsi, R.C. James and R.D. Harbison. 1987. The
dependence of male reproductive toxicity on germ cell stage. In: Functional
Teratogenesis: Functional Effects on the Offspring After Parental Drug Exposure,
T. Fuji and P.M. Adams (Eds.), Teikyo University Press, Tokyo, Japan, pg 133-143.
10. Gandy, J. and T. Imamura. 1987. A phosphorothionate isomer protects against the
pneumotoxicity caused by O,O,S-trimethyl phosphorothioate. Toxicol. Appl.
Pharmacol. 87:498-508.
11. Kerger, B.D., J. Gandy, T.J. Bucci, S.M. Roberts, R.D. Harbison and R.C. James.
1988. Antagonism of bromobenzene-induced hepatotoxicity by the alpha
adrenergic blocking agents, phentolamine and idazoxan. Toxicol. Appl.
Pharmacol., 95:12-23.
12. Imamura, T. and J. Gandy. 1988. Pulmonary toxicity of phosphorothioate
impurities found in organophosphate insecticides. Pharmacol. Ther., 38:419-427.
13. Kerger, B.D., S.M. Roberts, J.A. Hinson, J. Gandy, R.D. Harbison and R.C. James.
1988. Antagonism of bromobenzene-induced hepatotoxicity by phentolamine:
evidence for a metabolism independent intervention. Toxicol. Appl. Pharmacol.,
95:24-31.
14. Durham, S.K., J. Gandy and T. Imamura. 1988. Atrophine pretreatment does not
abrogate O,O,S-trimethyl phosphorothiate-induced bronchiolar injury in mice.
Toxicol. Pathology, 16:392-395.
15. Harbison, R.D., C.C. Conaway, L.F. Rubin and J. Gandy. 1989. A study of chronic
morpholine exposure in rats. Fund. Appl. Toxicol., 12:491-507.
16. Barnett, J. B. and J. Gandy. 1989. Effect of acute exposure on the immune
response of C57B1/6 mice. Fund. Appl. Toxicol., 12:757-764.
17. Stidman, J., E.H. Taylor, H.F. Simmons, J.Gandy, and A.A. Pappas. 1989.
Determination of meprobamate in serum by alkaline hydrolysis, trimethylsilyl
derivatization and detection by gas chromatography -mass spectrometry. J.
Chromatogr., 494: 318-323.
18. Mattison, D.R., D.R. Plowchalk, M.J. Meadows, A.Z. AI-Jubure, J. Gandy and A.
Malek. 1990. Reproductive toxicity: the male and female reproductive systems as
targets for chemical injury. Med. Clinics N. Am., 74:391-411.
19. Gandy, J., G.C. Millner, H.K. Bates, D.A. Casciano, and R.D. Harbison. 1990. The
effects of selected chemicals on the glutathione status of the male reproductive
system of rats. J. Toxicol. Eviron. Health, 29:45-57.
20. Barnett, J.B., B.L. Blaylock, J. Gandy, J.H. Menna, R. Denton and L.S.F.
Soderberg. 1990. Long-term alteration of adult bone marrow colony -formation by
prenatal chlordane exposure. Fund. Appl. Toxicol., 14:688-695.
06/22/20
21. Barnett, J.B., B.L. Blaylock, J. Gandy, J.H. Menna, R. Denton and L.S.F.
Soderberg. 1990. Alteration of fetal liver colony formation by prenatal chlordane
exposure. Fund. Appl. Toxicol., 15:820-822.
22. Blaylock, B.L., L.S.F. Soderberg, J. Gandy, J.H. Menna, R. Denton, and
J.B.Barnett. 1990. Cytotoxic T Lymphocyte and NK responses in mice treated
prenatally with chlordane. Toxicol. Lett., 51:41-49.
23. Seng, J.E., J.E. Leakey, M.P. Arlotto, A. Parkinson and J. Gandy. 1991. Cellular
localization of cytochrome P450IIAl in testes of mature Sprague-Dawley rats. Biol.
Reproduction, 45:867-882.
24. Barnett, J.B., J. Gandy, D. Wilbourn and S.A. Theus. 1992. Comparison of the
immunotoxicity of propanil and its metabolite, 3,4-dichloroaniline, in C57131/6 mice.
Fund. Appl. Toxicol., 18:628-631.
25. Gandy, J., H.K. Bates, L.A. Conder and R.D. Harbison. 1992. Effects of
reproductive tract glutathione enhancement and depletion on ethyl
methanesulfonate-induced dominant lethal mutations in Sprague-Dawley rats.
Teratogen. Carcinogen. Mutagen. 12:61-70.
26. Theus, S.A., D.R. Tabor, J. Gandy, and J.B. Barnett. 1993. Alteration of
macrophage cytotoxicity through endogenous interferon _ _ and tumor necrosis
factor induction by propanil. Toxicol. Appl. Pharmacol. 118:46-52.
27. Gandy, J., S.K. Durham and T. Imamura. 1993. Pulmonary toxicity induced by
phosphorothioate impurities present in organophosphate insecticides. In:
International Encyclopedia of Pharmacology and Therapeutics: Metabolic
Activation and Toxicity of Chemical Agents to Lung Tissue and Cells. T.E. Gram,
Ed., Pergamon Press, Oxford, p 153-163.
28. Primiano, T., J. Gandy, J.L. York and R.F. Novak. 1993. Enhanced glutathione S-
transferase 7-7 expression in rat hepatic cytosol following treatment with pyrrole.
Biochem. Biophys. Res. Comm. 190:1136-1142.
29. Evenson, D.P., L.K. Jost and J. Gandy. 1993. Glutatione depletion potentiates
ethyl methansulfonate-induced damage to sperm chromatin structure.. Repro.
Toxicol. 7:297-304.
30. Blyler, G., K.S. Landreth, T. Lillis, R. Schafer, S.A. Theus, J. Gandy, and J.B.
Barnett. 1994. Selective myelotoxicity of propanil. Fund. Appl. Toxicol. 22:505-510.
31. Zhao, W., R. Schafer, C.F. Cuff, J. Gandy, and J.B. Barnett. 1995. Changes in
primary and secondary lymphoid organ T cell subpopulations resulting from acute in
vivo exposure to propanil. J. Toxicol. Environ. Health 46:101-111.
32. Gandy, J., T. Primiano, R.F. Novak, W.R. Kelce, and J.L. York. 1996. Differential
expression of glutathione s-transferase isoforms in compartments of the testis and
segments of the epididymis of the rat. Drug Metabol. Disposition 24:725-733.
33. Seng, J.E., J. Gandy, A. Turturro, R. Lipman, R.T. Bronson, W. Johnson, R.W. Hart,
and J.E. Leakey. 1996. Effects of caloric restriction on expression of testicular
06/22/20
cytochrome P450 enzymes associated with the metabolic activation of carcinogens.
Arch. Biochem. Biophy. 335:42-52.
34. Ronis, M.J.J., L.M. Bell, J. Parker, M. Shaw, J. Gandy, T.M Badger, and K. Green.
1996. Neuroendocrine mechanisms underlying the reproductive toxicity of lead in a
rat lifetime exposure model. In: Metal Ions in Biology and Medicine, 4: 420-422. P.
Collery, J.L. Domingo, J.C. Etienne, J.M. Liobet (Eds.). John Libbey Eurotext,
Paris.
35. Ronis, M.J.J., J. Gandy, and T. Badger. 1998. Endocrine mechanisms underlying
the reproductive effects of developmental lead exposure in the rat. J. Toxicol.
Environ. Health 54:77-99.
36. Nye, A.C., G.C. Millner, J. Gandy, and P.T. Goad. Examples of risk assessment
applications. In: Williams, P. L, James, R. C., and Roberts, S. M., Editors. Principles
of Toxicology: Environmental and Industrial Applications. 2nd ed. New York: John
Wiley & Sons, Inc.; 2000; pp. 479-498.
37. Chang, H.C., J.E. Seng, J.E.A. Leakey and J. Gandy. 2000. Metabolism of
flutamide in diet control rats, and its hydroxylation and conjugation by human
CYP450s and UGT-glucuronosyltranferases. J Food Drug Anal. 8(3): 166-173.
38. Richards, S. M., G.Y. McClure, T.L. Lavy, J.D. Mattice, R.J. Keller, and J. Gandy.
2001. Propanil (3,4-dichloropropionanilide) particulate concentrations within and
near the residences of families living adjacent to aerially sprayed rice fields.
Archives Environ. Contam. Toxicol. 41:112-116.
39. McClure, G.Y.H., R.M. Helm, K. Stine, A.W. Burks, S.M. Jones and J. Gandy.
2001. Evaluation of immune parameters in propanil exposed farm families.
Archives Environ. Contam. Toxicol. 41:104-111.
40. Jones, S.M., A.W. Burks, H.J. Spencer, S. Lensing, P.K. Roberson, J. Gandy, and
R.M. Helm. 2003. Occupational asthma symptoms and respiratory function among
aerial pesticide applicators. Am. J. Indust. Medicine 43:407-417.
41. Golden, R., J. Gandy, and G. Vollmer. 2005. A review of endocrine activity of
parabens and implications for potential risks to human health. Crit. Rev. Toxcol.
35:435-458.
42. Thomas, N.I., N.D. Brown, L.C. Hodges, J. Gandy, L. Lawson, J.E. Lord, D.K.
Williams. 2006. Factors associated with work -related injury among hospital
employees. AAOHN J. 54: 24-31.
43. Thomas, N.I., N.D. Brown, L.C. Hodges, J. Gandy, L. Lawson, J.E. Lord, D.K.
Williams. 2006. Risk profiles for four types of work -related injury among hospital
employees: a case -control study. AAOHN J. 54: 61-68.
44. Ansari, R.A., and J. Gandy. 2007. Determining the transrepression activity of
xenoestrogen on NF-KB in Cos-1 cell by estrogen receptor -a (ER -a). Int. J. Toxicol.
26(5):441-9.
45. Hewitt, D.J. and J. Gandy. 2009. Characterization of a fatal methyl bromide
exposure by analysis of trapped air in the headspace of a water cooler. Am. J.
Indust. Medicine 52(7):579-86.
10 06/22/20
Dr. Gandy
Curriculm vitae
ABSTRACTS:
1. Imamura, T., J. Gandy and T.R. Fulkuto. 1983. Selective inhibition of rat
pulmonary microsomal enzymes by O,O,S-trimethyl phosphorothioate treatment.
The Toxicologist 3:42.
2. Gandy, J., T.R. Fukuto and T. Imamura. 1983. Sequential and dose -dependent
morphological alterations in the rat bronchiolar epithelium during O,O,S-trimethyl
phosphorothioate induced delayed toxicity. The Toxicologist 3:43.
3. Gandy, J., T.R. Fukuto and T. Imamura. 1983. Relationship of delayed death and
alteration of rat lung bronchiolar epithelium caused by trialkylphosphorothioate
structural analogues. Toxicol. Lett. 18:73.
4. Imamura, T., A. J. Gray, J. Gandy and T. R. Fukuto. 1983. Protective effects of
mixed -function oxidase inducers and inhibitors against O,O,S-trimethyl
phosphorothioate induced toxicity in rats. Toxicol. Lett. 18:73.
Imamura, T., J. Gandy and L. Hasegawa. 1984. Development of tolerance to a
pneumotoxic impurity of malathon. Fed. Proc. 43:761.
6. Gandy, J. and T. Imamura. 1984. The pneumotoxic effects of an impurity of
organophosphorus insecticides. Neurotoxicology 5:76.
7. Gandy, J. and T. Imamura. 1985. A phosphorothionate isomer protects against the
pneumotoxicity caused by O,O,S-trimethyl phosphorothioate, The Toxicologist
5:69.
8. Gandy, J. and T. Imamura. 1985. Kinetic response of alveolar and bronchiolar
cells to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats. Fed.
Proc. 44:719.
9. Millner, G.C., J. Gandy, D. Casciano and R.D. Harbison. 1986. The effect of
selected chemicals on glutathione (GSH) levels in the male reproductive tract. The
Toxicologist 6:290.
10. Kerger, B.d., R.D. Harbison, T.J. Bucci, R.C. James and J. Gandy. 1986.
Antagonism of bromobenzene-induced hepatotoxicity by the adrenergic blocking
agent, phentolamine. The Pharmacologist 28(3):180.
11. Harbison, R.D., J. Gandy and R.C. James. 1986. Confounding factors in risk
assessment. Annual Meeting of the American Society of Animal Science.
12. Gandy, J., C.M. Teaf, F.A. Adatsi and R.D. Harbison. 1986. The dependence of
male reproductive toxicity on germ cell stage. Satellite Symposium of the Fourth
International Congress of Toxicology, Tokyo, Japan, July, 1986.
13. Barnett, J.B., L. Buehler and J. Gandy. 1987. Immunotoxic effects of propanil in
mice. Fed. Proc. 46:539.
11 06/22/20
Dr. Gandy
Curriculm vitae
14. Kerger, B.D., J.A. Hinson, R.D. Harbison, S.M. Roberts, J. Gandy and R.C. James.
1987. Antagonism of bromobenzene-induced hepatotoxicity: Evidence for a
pharmacological intervention by phentolamine. The Pharmacologist 29(3):148.
15. Gandy, J., L.A. Buehler and R.D. Harbison. 1987. The role of reproductive tract
glutathione in protecting against sperm head alkylations. The Pharmacologist
29(3):221.
16. Bates, H.K., R.D. Harbison and J. Gandy. 1988. Circadian fluctuation of
glutathione levels in the reproductive tract of the male rat. The Toxicologist, 8:56.
17. Barnett, J., L. Soderberg and J. Gandy. 1988. Immunotoxic effects of propanil:
dose response studies. FASEB Journ. 2(4):A914.
18. Smith, M.A., J. Gandy, S.M. Roberts, R.C. James and R.D. Harbison. 1989.
Phentolamine antagonism of iodobenzene hepatotoxicity in B6C3F1 mice. The
Toxicologist, 9(1):60.
19. Bates, H.K., R.D. Harbison and J. Gandy. 1989. Potentiation of ethyl
methanesulfonate dominant lethality by phorone depletion of glutathione. The
Toxicologist, 9(1):91.
20. Buehler, L.A., R.D. Harbison and J. Gandy. 1989. The enhancement of glutathione
and its protective role against germ cell mutations. The Toxicologist, 9(1):91.
21. Barfield, L., J.B. Barnet, J. Gandy, D. Lattin and R.D. Harbison. 1989.
Distributional differences of 3,3',4,4'-tetrachlorobiphenyl in BALB/c and DBA mice.
FASAB Journ., 3(4):A1038.
22. Blaylock, B.L., L.S.F. Soderberg, J. Gandy, J.H. Menna and J.B. Barnett. 1989.
The effect of pre/postnatal exposure to chlordane on the body weight and
lymphocyte activity of BALB/c mice. FASAB Journ. 3(3):A603.
23. Gandy, J., H.K. Bates, L.A. Buehler and R.D. Harbison. 1989. Effects of
reproductive tract glutathione depletion and enhancement on ethyl
methanesulfonate-induced dominant lethal mutations. Internat. Congress Toxicol.:
150.
24. Durham, S.K., M.J.J. Gijels, J. Gandy and T. Imamura. 1989. Comparative long-
term morphologic and biochemical changes induced by O,O,S-trimethyl
phosphorothioate in the rat and mouse lung. Internat. Congress Toxicol.:91.
25. Seng, S.E., J.E. Leakey, M.P. Arlotto and J. Gandy. 1990. Age -dependent activity
of testosterone 7 -hydroxylation in isolated Leydig cells of testes from Sprague-
Dawley rats. The Toxicologist 10:124
26. Blaylock, B.L., J.B. Barnett, L.S.F. Soderberg, J.H. Menna and J. Gandy. 1990.
The effects of prenatal exposure to chlordane on the anti -influenza immune
response in BALB/c mice. The Toxicologist 10:290.
12 06/22/20
Dr. Gandy
Curriculm vitae
27. Gandy, J., T. Primiano, J.L. York and R.F. Novak. 1991. Differential expression of
class - and glutathione s-transferases in compartments of the testis.
The FASEB Journal, 5(6):A1570.
28. Frame, L.T. and J. Gandy. 1991. Glutathione localization in sertoli-germ cell
cocultures. The Toxicologist, 11:248.
29. York, J.L., T. Primiano, J. Gandy, and R.F. Novak. 1992. Comparison of
glutathione s-transferase expression in rat and rabbit testicular cytosol. The
Toxicologist, 12:169.
30. Gandy, J., S.K. Durham, K.L. Nevels and J.L. York. 1992. The effects of testicular
GSH levels and the role of glutathione transferases in DBCP-induced reproductive
toxicity. The Toxicologist, 12:395.
31. Theus, S.A., L.S.F. Soderberg, J. Gandy, and J.B. Barnett. 1992. Propanil
exposure alters IL-2 production. The Toxicologist, 12:50.
32. Seng, J.E., J. Gandy, R.W. Hart and J.E.A. Leakey. 1993. Localization and
regulation of testicular cytochrome P450 isoforms in rats. The Toxicologist, 13:92.
33. Barnett, J., W. Zhao, L. Soderberg and J. Gandy. 1993. Propanil immunotoxicity on
T cell interferon- and IL-6 production. The Toxicologist, 13:325.
34. Primiano, T., J. Gandy, J.L. York and R.F. Novak. 1993. Induction of rat hepatic
cytosolic glutathione S-transferase expression following treatment with isosafrole.
The Toxicologist, 13:330.
35. York, J.L., T. Primiano, J. Gandy and R.F. Novak. 1993. Glutathione S-transferase
expression in rat hepatic cytosol following treatment with pyrrole. The Toxicologist,
13:330.
36. Blyer, G., K. Landreth, S. Theus, L. Soderberg, J. Gandy and J. Barnett. 1993.
Propanil immunotoxicity on bone marrow stem cells. The Toxicologist, 13:422.
37. Seng, J.E., J. Gandy, M. Manjgaladze, R.W. Hart and J.E.A. Leakey. 1994. Effects
of caloric restriction on cytochrome P450-dependent monooxygenase activities in
rat testes. Presented at: Dietary Restriction -Implications for the Design and
Interpretation of Toxicity and Carcinogenicity Studies. Washington, D.C.
38. Gandy, J., J.E. Seng, J.L. York, T. Primiano and J.E.A. Leakey. 1994. Isosafrole
alters cytochrome P450 IA activity and glutathione S-transferase expression in the
rat testis. The Toxicologist, 14:86.
39. Barnett, J., K. Landreth, T. Lillis, R. Schafer and J. Gandy. 1994. Effects of
propanil on splenic hemopoiesis. The Toxicologist, 14:396.
40. Gandy, J., S.K. Durham and T. Imamura. 1994. Cellular and biochemical
mechanisms of lung injury induced by trialkylphosphorothioates. Union des
Societes Suisses de Biologie Experimentale, Berne, Switzerland.
13 06/22/20
Dr. Gandy
Curriculm vitae
41. Manjgaladze, M., N. Kozlovskaya, J.E. Seng, J.E.A. Leakey and J. Gandy. 1994.
Effects of inducers and inhibitors of cytochrome P450 (CYP 1 A1) on microsomal 7-
ethoxy- and 7-benzoxyresorufin metabolism in various rat tissues. ISSX
Proceedings, 6:203.
42. Seng, J.E., J. Gandy, O. Awad, R. Lipman, R.T. Bronson, R.W. Hart and
J.E.Leakey. 1995. Effects of dietary restriction on expression of testicular
cytochrome P450isoforms associated with the metabolic activation of carcinogens.
ISSX Proceedings, 8:333.
43. Ronis, M.J.J., T.M. Badger, J. Gandy, L.M. Bell and K. Green. 1995. Anti -
androgenic effects of perinatal cypermethrin exposure in the developing rat.
Internatl. Congress Toxicol.- VII.
44. Gandy, J., J.E. Seng, V.M. Baker, O. Awad, R.W. Hart and J.E. Leakey. 1996.
Flutamide-induced rat testicular tumors and lypoxygenase activities are reduced by
caloric restriction. Fund. Appl. Toxicol., Suppliment, 30:122.
45. Gandy, J., S.M. Richards, J.D. Mattice and T.L. Lavy. 1996. Airborne
concentrations of propanil within residences of families living adjacent to aerially
sprayed rice fields. Am. Industrial Hygiene Conf.
46. McClure, G.Y.H., R.M. Helm, A.W. Burks and J. Gandy. 1996. Evaluation of the
immunotoxic properties of the herbicide, propanil, in farm families. Am. Industrial
Hygiene Conf.
47. McClure, G.Y.H., R.M. Helm, K. Stine, A.W. Burks, S.M. Jones, and J. Gandy.
1997. Evaluation of immune parameters in propanil exposed farm families. Fund.
Appl. Toxicol., Suppliment, 36:264.
48. Chang, C.-W., J. Seng, J.E. Leakey, R.W. Hart, and J. Gandy. 1997. Diet -induced
changes in testicular toxicity of flutamide are mediated via altered LH and
hydroxyflutamide levels. Fund. Appl. Toxicol., Suppliment, 36:356.
49. Gandy, J., S.W. Williams, R. Hill, and P.T. Goad. 1999. Determination of
acceptable exposure limits for the anti -viral agent ribavirin. Toxicological Sci,
Supplement, 48:80.
50. Gandy, J. and A.J. Harris. 2005. Health effects reported in Texas homes with visible
mold and/or water damage. The Toxicologist 84:86.
51. Nony, P., D.W. Gaylor, G.C. Millner, A.C. Nye, and J. Gandy. 2008. Residual
PAHs, PCBs, PCDDs, and PCDFs in soil and house dust following an industrial
chemical release and fire. 2008 Itinerary Planner No. 801. Society of Toxicology.
52. Gandy, J. and Cranmer, M.F. 2014. University of Arkansas for Medical Sciences
(UAMS) Regulatory Sciences Training and Research Program - A partnership
between UAMS and NCTR. Montreal, Canada.
53. Gandy, J. and Cranmer, M.F., Harril, A. 2015. University of Arkansas for Medical
Sciences (UAMS) Regulatory Sciences Training and Research Program - A
partnership between UAMS and NCTR. Parma, Italy.
14 06/22/20
Dr. Gandy
Curriculm vitae
54. Gandy, J. 2017. University of Arkansas for Medical Sciences (DAMS) Regulatory
Sciences Training and Research Program — A partnership between UAMS and
NCTR. Global Summit on Regulatory Sciences, Brasilia, Brazil.
15 06/22/20
HUDA SHARAF, M.D.
BOARD CERTIFIED INTERNAL MEDICINE
2525 North Fennchurch Way • Fayetteville, Arkansas • (479) 200-7517 • hudamai@aol.com
EDUCATION & LICENSES
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE — ST. LOUTS, MISSOURI JUNE 2000
Residency, BARNES-JEWISH HOSPITAL
Internal Medicine/Categorical Track
• Twin Studies Lecture for Internal Medicine Grand Rounds
• CHF research study with Dr. Joe Rogers
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE — ST. LOUTS, MISSOURI JUNE 1998
Internship, BARNES-JEWISH HOSPITAL
Internal Medicine/Categorical Track
UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES — LITTLE ROCK, ARKANSAS MAY 1997
Doctor of Medicine, 3.60 GPA, Rank 13/123
• Alpha Omega Alpha Honor Society
UNIVERSITY OF ARKANSAS — FAYETTEVILLE, ARKANSAS MAY 1993
Bachelor of Science in Chemistry, 3.68 GPA
• Cum Laude
LICENSED PHYSICIAN — State of Arkansas
PROFESSIONAL EXPERIENCE
MEDICAL DIRECTOR/STAFF PHYSICIAN — FAYETTEVILLE, ARKANSAS
University of Arkansas JANUARY 2008 — PRESENT
Primary care physician for The Pat Walker Health Center which provides healthcare for the
University community to include students, faculty and staff. Serve as physician collaborator for
an APRN. Served as Medical Director from September 2010 through August 2012 and assumed
the permanent position in February 2013.
STAFF PHYSICIAN — ST. LOUTS, MISSOURI OCTOBER 2003 — NOVEMBER 2007
Washington University
Primary care physician for Washington University Student Health Center which provides
healthcare for 11,000 students. Served as physician collaborator for a PA and an APN.
CLINICAL INSTRUCTOR — ST. LOUTS, MISSOURI AUGUST 2001— OCTOBER 2003
Emergency Medicine Division, Washington University School of Medicine
Staffed ER patient cases with APNs, PAs and residents. Served as the physician collaborator for
an APN.
CLINICAL ASSISTANT PROFESSOR— GAINESVILLE, FLORIDA AUGUST 2000—JUNE 2001
Internal Medicine Division, University of Florida
Primary care physician for outpatient and inpatient care for a 300 bed hospital. Rotated call with
hospitalist group with responsibilities to include patient admission, ICU management, pre -op
clearance and carried CODE beeper.
♦ Voluntarily mentored and trained medical students as a Physical Diagnosis Course
Instructor.
CERTIFICATIONS
& MEMBERSHIPS
Board Certified in Internal Medicine
BLS
ACP Member
HOBBIES & INTERESTS
Spending Time with Family ♦ Reading ♦ Traveling
Gary Berner M.D.
Chief Medical Officer at Community Clinic
gbemer@communityclinicnwa.org
RESIDENCYANTERNSHIP
7/12- 6/16 UAMS; Little Rock, AR
Internal Medicine & Pediatrics
EDUCATION
8/08- 5/12 UAMS- College of Medicine; Little Rock, Arkansas
Doctor of Medicine
8/03- 5/07 Hendrix College; Conway, AR
Bachelor of Arts in Biology
8/01- 5/03 Russellville High School; Russellville. AR
EMPLOYMENT
8/16- Present Community Clinic of Northwest Arkansas
Began practicing in General Internal Medicine & Pediatrics at the
location in Fayetteville. In January 2019 I took over the role as Chief Medical Officer. I
give advice to the administrative team on best medical practices, preventative care, de-
velop new programing (including Pre -Exposure Prophylaxis for HIV, Medication As-
sisted Treatment for Opioid Addiction, Hepatitis C Treatment Program, and others), liai-
son to local health partners (ACNW, UAMS, Childrens Safety Center, etc.), oversee
UAMS Resident and Medical Student Education, collaborating physician to our nurse
practitioners, manage recruiting and staffing of medical providers, and consultant to phy-
sicians and NPs on complex medical cases. I oversaw the development and implementa-
tion of Community Clinics robust response to the COVIDI9 Pandemic.
7/07- 7/08 Hendrix College; Conway, AR
Research Assistant- My responsibilities began by running the ex-
periments, collecting data, and analyzing the results. Additionally I monitored the needs
and supplies for the lab. By 10/07, my role transitioned to teaching and supervising un-
dergraduate researchers to do the same.
HONORS AND AWARDS
5/16 UAMS Pediatric Critical Care Resident of the Year. Winner
3/16 UAMS Resident of the Year. Runner Up
7/15- 6/16 Chief Resident. Internal Medicine & Pediatrics.
3/15- 6/16 Chairmen's Scholar. Arkansas Children's Hospital
'08-` 12 Arkansas Rural Medicine Practice Scholarship. UAMS.
2003- 2007 Hendrix College Soccer. 4 years Varsity, All -Conference '04 &
'06, Academic All -Conference '03- '07, Captain `06
PROFESSIONAL ORGANIZATIONS
8/08- present AAP
LICENSURES/CERTIFICATIONS
Arkansas Medical License
Board Certified Pediatrician
Board Eligible Internal Medicine Physician
BLS, PALS Certified
EXTRACURRICULAR ACTIVITIES
7/09- 8/09 Medical Mission Trip. Lilongwe, Malawi.
Current Member of St. Pauls Episcopal Church. Fayetteville, AR
Current Hendrix College Alumni Board. Conway, AR
RESEARCH & PUBLICATIONS
Resarch Projects
7/07- 8/08 Interactions of Histone Protein Complex with DNA
Genetics Department- Andrea Duina (PI)
Hendrix College- Conway, AR
Project: The goal in our lab was to gain
insights into the process of eukaryotic gene transcription.
Playing particular interest to the interactions that occur
between the histone chaperone complex and chromatin
during transcription.
2
Publications
Myers CN, Berner GB, Duina A, et all. Mutant Versions of the S. cerevisiae Transcrip-
tion Elongation Factor Spt16 Define Regions of Spt16 That Functionally Interact with
Histone H3. PLoS One. 2011; 6(6): e20847.
PERSONAL
7/2/11- Present. Happily married to Ryan Hughes Berner- RN at Arkansas Children's
Northwest. Father to Ruby and Hazel.
Interests- Cooking and canoeing with my wife. Hiking with the family and our dog.
Watching and playing soccer when free time allows. Dabbling in woodworking, fly fish-
ing, and music.
3
Joey Gardner, DSW, LCSW
4055 W. Song Bird PI
Fayetteville, AR 72704
JoeyJGardner@gmail.com
870-692-1440
CURRICI LI NI VITAE
EDUCATION
DSW Walden University; School of Social Work
2018 Doctoral Program; Minneapolis, Minnesota
Dissertation: "Understanding Social Workers' Knowledge of Foster
Care Drift", Administrative Concentration
MS Walden University; Information Technology
Minneapolis, Minnesota; Health Informatics Concentration
2019-Present
MSW University of Southern California; School of Social Work-
2013 Los Angeles California; Mental Health Concentration
BA University of Arkansas; Fayetteville, Arkansas;
2012 Sociology and Criminal
ACADEMIC RESEARCH EXPERIENCE
Dissertation: Understanding Social Workers' Knowledge of Foster Care Drift (Fall
2018)
CONTRIBUTIONS TO THE UNIVERSITY AND COMMUNITY
Instructor
Adjunct Instructor-UAPTC, 2019-present
Advising
Academic Advisor UoA —Autism Support Program, 2012- 2015
Academic Advisor UoA- Freshman Engineering Program, 2010
Other Contributions
Center of Training Transportation Professional -Proctor UoA, 2009
National Cares Mentoring Movement- Board Member Pine Bluff, AR 2013-present
Martin Luther King Planning Committee -Board Member, 2011-2013
SPECIAL AWARDS
National Honor Society, Criminal Justice- UoA
Selected for inclusion in Who's Who in American Universities and Colleges- UoA
National Honor Society, Social Work -University of Southern California
PROFESSIONAL AFFILIATIONS
National Association of Social Workers (Arkansas Chapter) — 2016-present
Kappa Alpha Psi, Fraternity Inc. Fayetteville Alumni Chapter
National Cares Board Member (Pine Bluff, AR)
ICVR, King Team Board Member (Pine Bluff, AR)
SOCIAL WORK PRACTICE EXPERIENCE
3/20-5/20, Vantage Point. Fayetteville, Arkansas. Director of Admissions
Supports team in facilitating incoming inquiries of prospective clients, loved
ones and mental health/medical professionals with a sense of urgency and
compassion. Exhibits a high level of professionalism and excellent customer
service skills with each call, tour and admission. Obtains clinical information
and other medical information to determine appropriateness for TK. Assist
callers in identifying the benefits of TK program as relevant to their individual
situation. Utilizes an Intervention style approach (when applicable) to assist
callers in working through ambivalence. Prepares and facilitates all aspects
of the admissions process, including all intake paperwork. Maintains
Salesforce database by entering incoming and outgoing calls
5/18-2/20, 5/20-Present: Beacon Health Options. Little Rock, AR. Supervisor, Care
Coordinator Supervisor
Oversee day-to-day operations within the Clinical Department for functions
handled by non -licensed clinical staff; Ensures assigned staff complete all
requirements of the program as outlined by Arkansas Medicaid, Ensure
process and procedures are followed consistently, and the program
operations run seamlessly; Responsible for training, meetings, scheduling,
monitoring productivity, and overall management of assigned staff;
Responsible for identifying operational issues which could impact clients and
members; Participate in strategic, systems, and organizational planning of
department and the company as a whole.
12/16-5/1 & Beacon Health Options. Little Rock, Arkansas. Care Manager.
Maintain confidentiality, ethical professional standards, adhering to clinical
policy and procedures and benefit plan requirements; Utilize rounds and
case consults with clinical supervisor, peer advisor for cases outside criteria
or not processing; Review and process prior authorizations for inpatient and
outpatient services; Care coordination/Reintegration management.
5/15-12/16: Vantage Point of Northwest Arkansas. Fayetteville Arkansas. Intake
Coordinator.
Cultivated strong business relationships to drive organization development;
Ensured organization is prepared for internal audits through
analysis/preparation of medical records; Administered financial processes
including verifying and precertification of third party insurances; Process
admissions forms required by regulating agencies; Interview clients, review
records, conduct assessments, or confer with other professionals to evaluate
the mental or physical condition of clients or patients; Collaborate with
counselors, physicians, or nurses to plan or coordinate treatment, drawing on
social work experience and patient needs.; Refer patient, client, or family to
community resources for housing or treatment to assist in recovery from
mental or physical illness, following through to ensure service efficacy.
1/14-5/15: Ozark Guidance. Fayetteville, Arkansas. Mental Health Professional
Conduct psychosocial assessments and master treatment plans; Treatment
team staff meetings with site director and treatment team; Fill out and
maintain client -related paperwork, including federal and state mandated
forms; client diagnostic records, and progress notes; case management
4/13-11/13: CREOKS Behavioral Health Services. Stilwell, Oklahoma. Behavioral Health
Rehabilitation Specialist
Responsible for teaching rehabilitative skills necessary for performing
activities of daily; Conducts psychosocial assessments and master treatment
plans for clients; Parenting, substance abuse, and adult education groups
8/12-5/15: Autism Support Program, University of Arkansas, Fayetteville, Arkansas.
Academic Coach.
Provides support to students with high functioning autism, Asperger's
Syndrome, PDD-NOS, and non-verbal learning disabilities; Assisted students
in developing in three critical areas: academic, the transition to independent
adult roles, and proper use of social skills.
5/11-8/11: Department of Community Corrections- Fayetteville, Arkansas. Intern.
Compiled information regarding clients' progress in society; Set-up
employment searchers for clients; organized and maintained documents;
prepared social histories.
STEPHANIE A. HO, M.D.
1590 E Joyce Blvd, #9301, Fayetteville, AR 72703 1 501-590-0657 1 hostephaniea yahoo.com
Curriculum vitae
POST -RESIDENCY CLINICAL PRACTICE AND TRAINING
VECTOR HEALTH & WELLNESS, LLC 2019 - present
Vector Health & Wellness, LLC, Primary Care, Gender Transition Services and Sexual/Reproductive Health
1267 N Steamboat Dr, Ste 3, Fayetteville, AR 72703 ) ph. 479-316-6565 1 fax 479-316-0331
Responsibilities
Lab Director (CLIA waived)
Family Medicine and Preventative Care
Evaluation, Diagnosis, Treatment and Prevention of common conditions for all ages:
Chronic conditions - type I and II diabetes, hypertension, high cholesterol, uncomplicated hypothyroidism and hyperthyroidism,
mild COPD, mild asthma, uncomplicated urinary incontinence, mild anxiety, mild depression, simple benign prostate
hypertrophy, uncomplicated nephrolithiasis, uncomplicated rheumatoid arthritis, osteoarthritis, osteoporosis, mild anemia, etc.
Acute conditions - cough, colds, strep throat, flu, uncomplicated poison ivy, mild to moderate respiratory infections, mild to
moderate skin infections, mild eye infections, seasonal allergies, etc.
In -office procedures (mole removal, laceration repair, diabetic foot exam,)&D, etc.)
Vaccine administration, EPSDT exams, school/sports physicals, wellness exams, cardiac clearance evaluations
Initial and Subsequent Annual Medicare Wellness Exams
Referrals for specialist care, medical nutrition therapy, diabetic education, etc.
Referrals for pain management, moderate to severe anxiety/depression and child/adult ADHD
Family Planning and Options Counseling
Comprehensive options counseling
Reviewing, interpreting and signing -off on transvaginal and transabdominal ultrasounds
Identification, management and referrals for early pregnancy loss and ectopic pregnancies
Referrals for adoption and prenatal care
Informed consent for elective termination, including consent/counseling on the Arkansas State -Mandated Information
and materials
Interpretation of transvaginal ultrasound and quantitative hCG to confirm the completion of medication abortion
Comprehensive contraceptive counseling
Insertion/removal of subdermal implants and intrauterine devices for contraception
STD testing and treatment, including expedited partner treatment
Referrals for hepatitis C and syphilis treatment
Clinical breast exam and referrals for screening and diagnostic mammograms
Cervical cancer screening and pelvic exams
Diagnosis and treatment of pelvic inflammatory infections
Diagnosis and treatment of urinary tract infection, vaginal yeast infection, trichomoniasis and bacterial vaginosis
Screening and referrals for intimate partner violence and domestic violence
Trained to detect and report victims of human trafficking
Mandatory reporting
Pre -conception counseling
Initiation of prenatal care (counseling, first labs, referral for diagnostic ultrasound and assistance in finding OB provider)
Transgender/LGBTQ Care Provider
HRT, referrals for gender affirming surgery, assistance with insurance and name/gender change, etc.
LGBTQ-friendly primary and lifestyle -specific care
Community outreach in support of the LGBTQ population
HIV Care
Ryan White Provider
Starting and maintaining ART in collaboration with Arkansas Department of Health infectious disease specialists
Risk assessment and counseling
PrEP and PEP treatment options
Collaborating physician for 1 APRN in Fayetteville, AR
STEPHANIE A. HO, M.D.
PAGE 2
PLANNED PARENTHOOD GREAT PLAINS (PPGP, formerly PP Heartland), FAYETTEVILLE, AR - CLINICAL PRACTICE 2013 - 2019
Planned Parenthood of Arkansas and Eastern Oklahoma
3729 North Crossover, Suite 107, Fayetteville, AR 72703 1 ph. 479-443-7792 1 fax 479-444-6146
Leadership Roles
Program Director for Primary Care Services for the PPGP affiliate
Lab Director (CLIA moderate -complexity) for Planned Parenthood Great Plains' Arkansas clinics (2013 - 2019)
Lab Director (CLIA moderate -complexity) for Planned Parenthood Great Plains' Oklahoma clinics (7/2018 - 2019)
Primary Care, Transgender Care, Abortion Care, Family Planning and HIV Care provider for the Fayetteville, AR clinic
Responsibilities
Family Medicine and Preventative Care
Evaluation, Diagnosis, Treatment and Prevention of common conditions for all ages
In -office procedures (mole removal, laceration repair, contraceptive device placement, pap smears, diabetic foot exam, I&D, etc)
Collaborative agreement with a local hospitalist group for inpatient/observation admissions
Vaccine administration, EPSDT exams, school/sports physicals, wellness exams, cardiac clearance evaluations
LGBTQIA-friendly primary and lifestyle -specific care
Provide certification forms for patients seeking medical marijuana in Arkansas and Oklahoma
Transgender Care
Hormone replacement therapy prescriptions and management
Specialist referrals
Assistance with insurance and name/gender change, etc
Safety letters and letters of support for surgery and name/gender changes
Family Planning
Comprehensive contraceptive counseling
Insertion/removal of subdermal implants and intrauterine devices for contraception, insertion of Paragard for emergency
contraception
Counseling and prescriptions for emergency contraception
STD testing for gonorrhea, chlamydia, trichomonas, HIV, hepatitis B/C and syphilis
STD treatment, including expedited partner treatment, for gonorrhea, chlamydia and trichomonas
Referrals for hepatitis B/C and syphilis treatment
Clinical breast exam and referrals for screening and diagnostic mammograms
Cervical cancer screening and pelvic exams
Diagnosis and treatment of pelvic inflammatory infections
Diagnosis and treatment of urinary tract infection, vaginal yeast infection, trichomonas and bacterial vaginosis
Screening and referrals for intimate partner violence and domestic violence
Trained to detect and report victims of human trafficking
Mandatory reporting
HIV Care
Ryan White Participant and Provider
Diagnosis, treatment and management of HIV in collaboration with the Arkansas Department of Health Infectious Disease specialists
PrEP and nPEP regimen evaluation, prescriptions and management
Abortion Care
Comprehensive options counseling
Performing, reviewing, interpreting and signing -off on transvaginal and transabdominal ultrasounds for early pregnancy dating
Referrals for adoption and prenatal care
Miscarriage management
Identification, management and referrals for early pregnancy loss and ectopic pregnancies
Medication abortion
PHYSICIANS FOR REPRODUCTIVE HEALTH: LEADERSHIP TRAINING ACADEMY FELLOWSHIP - TRAINING 10/2017 - 6/2018
Background - The Physicians for Reproductive Health Leadership Training Academy prepares physicians to become lifelong leaders in
reproductive health care advocacy by helping them develop and internalize the skills they need to be powerful, effective
advocates for comprehensive sexual and reproductive health care. Training includes expert instruction in on -camera media
training and writing for different platforms, fighting for timely policy action by visiting legislators on Capitol Hill and in their
home state and collaborating with allied organizations advancing access to abortion, contraception, and sexual health
services.
Program Director - Libby Benedict
PLANNED PARENTHOOD GREAT PLAINS, OVERLAND PARK, KS - TRAINING 8/2017
4401 W 109TH St, Suite 100, Overland Park, KS 66211 1 913-345-1400
Supervising Physician - Orrin Moore, MD
Observation of therapeutic abortions, sedation, analgesia and paracervical block
STEPHANIE A. HO, M.D.
PAGE 3
SOLO PRIVATE PRACTICE - CLINICAL PRACTICE 8/2011 - 2/2017
Stephanie Ho MD PA
1420 South I Street, Fort Smith, AR 729011 ph. 479-434-3779 1 fax 479-434-3895 1 stephaniehomdpa.vpweb.com
Responsibilities
Family Medicine and Preventative Care
Evaluation, Diagnosis, Treatment and Prevention of common conditions for all ages
In -office procedures (mole removal, laceration repair, contraceptive device placement, pap smears, diabetic foot exam, I&D, etc)
Direct admission to Sparks Regional Medical Center for appropriate issues
Vaccine administration, EPSDT exams, school/sports physicals, wellness exams, cardiac clearance evaluations
Venipuncture, urine dip, pregnancy tests
CLIA-waived Lab Certification
Ryan White Provider
Transgender Care Provider (hormone replacement therapy, specialty referrals, assistance with insurance and name/gender change, etc)
LGBTQIA-friendly primary and lifestyle -specific care
Community outreach in support of the LGBTQI population
Sponsor of self-defense training for members of RVEC
LITTLE ROCK FAMILY PLANNING SERVICES - TRAINING 2013
4 Office Park Drive, Little Rock, Arkansas 72211 1 501-225-3836
Supervising Physician - Tom Tvedten, MD
Observation of therapeutic abortions
REPRODUCTIVE HEALTH ACCESS PROJECT (RHAP) - TRAINING 2012
GAPS Fellowship (GAPS - Graduate Abortion Provider Support)
Background - In 2012 RHAP launched the GAPS Fellowship to provide family physicians rendering care in critically underserved areas
with intensive support to integrate abortion in to their clinical practice. GAPS Fellows commit to integrating early
abortion care into their practice. I was the program's first fellow.
Fellowship Coordinator - Susan Yanow (susanCatsusanyanow.com
MOONLIGHTING - CLINICAL PRACTICE
Johnson Regional Medical Center 2011- 2013
1100 East Poplar Street, Clarksville, AR 72830 1 479-754-5454
Responsibilities
Hospitalist - admit new patients, daily rounds on local physicians' hospitalized patients, assist in triage of emergency room patients,
assist with transfer of critical patients, assist with Cesarean section and newborn resuscitation
INFORMAL CONSULTS FOR OPTIONS COUNSELING/TERMINATION REFERRALS - CLINICAL PRACTICE
Little Rock Family Planning Services 2015 - PRESENT
Arkansas State -Mandated Counseling - provided to local women to eliminate the need for them to
travel to Little Rock more than once for their therapeutic abortion
Sebastian County Health Department 2011- PRESENT
Sparks Regional Medical Center (now Baptist Health) Emergency Room 2009 - PRESENT
UAMS AHEC Fort Smith 2009 - PRESENT
POST -DOCTORAL CLINICAL PRACTICE AND TRAINING
PLANNED PARENTHOOD OF THE ROCKY MOUNTAINS, DENVER, CO - CLNIICAL PRACTICE AND TRAINING 10/2010
7155 East 38th Avenue, Denver, CO 80207
Supervising Physician - Savita Ginde, MD
Contraceptive counseling
Implanon and IUD placement
Transvaginal and transabdominal evaluation and dating of early pregnancy
Options counseling for unintended pregnancy
Referrals for prenatal care and adoption
Consent for elective abortion
Evaluation, Diagnosis, Management and Referrals for ectopic pregnancy and early pregnancy loss
Sedation and analgesia
Paracervical block
Therapeutic abortion
Post -abortion care and follow-up
Referrals for domestic violence, grief or other psychological counseling
STEPHANIE A. HO, M.D.
PAGE 4
RESIDENT MOONLIGHTING - CLINICAL PRACTICE
Johnson Regional Medical Center 2011 - 2013
1100 East Poplar Street, Clarksville, AR 72830 1 479-754-5454
Responsibilities
Hospitalist - admit new patients, daily rounds on local physicians' hospitalized patients, assist in triage of emergency room patients,
assist with transfer of critical patients, assist with Cesarean section and newborn resuscitation
Sequoyah Memorial Hospital Winter 2011
213 East Redwood Avenue, Sallisaw, OK 74955 1 918-774-1100
Responsibilities
Emergency room physician - triage of ambulance and walk-in patients, stabilization of critical patients (airway management, cardiac
monitoring, fluid resuscitation and management), evaluation, diagnosis and treatment of common
emergent and urgent medical problems
Perspective Behavioral Health Management 2010 - 2011
1340 South Waldron Road, Fort Smith, AR 72903 1 479-783-5353
Supervising Physician - Max Baker, MD
Responsibilities - initial evaluation (intake) of new patients; initiating treatment for depression, PTSD, anxiety, bipolar disorder, etc in
adults; initiating treatment for depression, ADHD, PTSD, anxiety, adjustment disorders, etc in children
St. Edward Mercy Medical Center 2010 - 2011
7301 Rogers Avenue, Fort Smith, AR 72903 1 479-314-6000
Responsibilities
Emergency room "Minor Medical" - triage of ambulance and walk-in patients, treatment of non -emergent medical complaints, assist
with outpatient follow up, arrange outpatient referrals
River Valley Urgent Care 2010 - 2011
3505 South 79th Street, Fort Smith, AR 72903 1 479-709-8686
Responsibilities
Triage of patients requiring higher level of care
Evaluation, diagnosis and treatment of minor emergencies or medical problems (lacerations, fracture management and splinting,
upper respiratory tract infections, rashes, allergic reactions, migraines, asthma/COPD exacerbations, etc)
Management of patients with chronic diseases that do not have a primary care provider (diabetes, hypertension, COPD, etc.)
Arranging outpatient studies and referrals
RESIDENCY - CLINICAL PRACTICE AND TRAINING 2009 - 2011
UAMS - AHEC West (University of Arkansas for Medical Sciences - Area Health Education Center)
612 South 12th Street, Fort Smith, AR 72901 1 479-785-2431
Supervising Physician - Jimmy Acklin, MD
Affiliated Teaching Hospital - Sparks Regional Medical Center (1001 Towson Avenue, Fort Smith, AR 729011 ph. 479-441-4000)
Responsibilities
All duties from Internship
Supervision of 15t and 2"d year residents
ICU and Labor and Delivery management
Good Samaritan charity clinic
INTERNSHIP - CLINICAL PRACTICE AND TRAINING 2008 - 2009
UAMS - AHEC West (University of Arkansas for Medical Sciences - Area Health Education Center)
612 South 12th Street, Fort Smith, AR 72901 1 479-785-2431
Supervising Physician - Jimmy Acklin, MD
Affiliated Teaching Hospital - Sparks Regional Medical Center (1001 Towson Avenue, Fort Smith, AR 729011 ph. 479-441-4000)
Responsibilities
Supervision of medical students
Hospital floor patient management, assistance with labor and delivery (including Cesarean section), ER admissions
Family Medicine outpatient continuity clinic
Respond to all "Rapid Response" and "CODE BLUE" calls
STEPHANIE A. HO, M.D.
PAGE 5
EDUCATION
MEDICAL SCHOOL 2004 - 2008
University of Arkansas for Medical Sciences (UAMS), College of Medicine
4301 West Markham Street, Little Rock, AR 72205 1 501-686-7000
Degree: Doctor of Medicine
UNDERGRADUATE 1999 - 2004
University of Arkansas
Fayetteville, AR
Degree: Bachelors of Science in Microbiology
Graduated Cum Laude
Thesis: Avian Inflammatory and Antibody Response to Intracellular Pathogens with Chemical Enhancement
TEACHING EXPERIENCE
Supervision and formal teaching of medical students, RNs, APRNs and CNAs 2019 - present
Guest Lecturer: "When Doctors Refuse to Treat LGBT Patients" for Arkansas College of Osteopathic Medicine V14119
Fort Smith, AR
Guest Lecturer: "Transgender Health" for Arkansas College of Osteopathic Medicine, Fort Smith, AR Fall 2018
Adjunct faculty for UAMS Northwest Regional Campus, Fayetteville, AR 6/2018 - 2019
Precepting/teaching 3rd and 4th year medical students during their OB/GYN and Family Medicine rotations
Collaborating physician for family medicine and women's health nurse practitioners within the 2016 - 2019
Planned Parenthood Great Plains' Arkansas and Eastern Oklahoma clinics
Supervision and formal teaching of nurse practitioners on transgender care services 2017
Supervision and formal teaching of a nurse practitioner student on her family medicine rotation 2014
Supervision and formal teaching of a medical resident on his private practice family medicine rotation 2012
Supervision and formal teaching of my clinical assistant 2011- 2016
Supervision and formal teaching of in and 2"d year medical residents 2009 - 2011
Supervision and formal teaching of nursing, pharmacy and medical students by the bedside and during rounds 2008 - 2011
CERTIFICATIONS/EXAMS/LICENSES
CERTIFICATIONS
American Board of Family Medicine, Board Certification ID: 150664 2018 - 2028
ACLS (Advanced Cardiac Life Support) 2008 - 2014
ALSO (Advanced Life Support in Obstetrics) 2009 - 2014
ATLS (Advanced Trauma Life Support) 2010 - 2014
CPR/First Aid/AED - BLS (Basic Life Support) 2003 - 4/20
NIH Stroke Scale Certification 2010 - 2012
NRP (Neonatal Resuscitation Program) 2008 - 2010
PALS (Pediatric Advanced Life Support) 2008 - 2014
EXAMS
MCAT 2004
USMLE (Step 1) 6/2006
USMLE (Step 2 CS) 6/2007
USMLE (Step 2 CK) 8/2007
USMLE (Step 3) 6/2009
LICENSES
Arkansas State Medical Board: E-6359 2010 - 7/31/20
DEA License - Fayetteville, AR: FH1836153 2010 - 10/31/21
DEA License - OKC, OK: FH7863714 8/29/18 - 10/31/21
DEA License - Edmond, OK: FH7863702 8/29/18 - 10/31/21
DEA License - Tulsa, OK: FH7863699 8/29/18 - 10/31/21
OBNDD (Oklahoma Board of Narcotics and Dangerous Drugs): 41109 2010-2013, 7/27/17 - 10/31/20
Oklahoma State Medical License: 28037 2010 - 2012, 8/17 - 8/1/20
Missouri State Medical License: 2017022652 2017 - 1/31/20
Kansas State Medical License: 04-39932 5/5/17 - 7/31/20
KaMMCO Policy ID: KSP0026726 7112/17 - 7/12/20
Colorado State Medical Board: DR.0061254 8/31/18 - 4/30/21
STEPHANIE A. HO, M.D.
PAGE 5
PROFESSIONAL AFFILIATIONS
Member, Reproductive Health Access Project (GAPS Fellow, Class of 2012)
Member, Physicians for Reproductive Health (LTA Fellow, Class of 2018)
Member, National Abortion Federation
Member, American Medical Association
Member, American Academy of Family Physicians
Member, Arkansas Medical Society
Member, World Professional Association for Transgender Health (WPATH)
Member, Gay and Lesbian Medical Association (GLMA)
Physician Supporter, Arkansas for Compassionate Care
Physician Supporter, Northwest Arkansas Center for Equality
Physician Supporter, River Valley Equality Center (RVEC)
Physician Supporter, Trans Equality Network
Board Member at Large, PFLAG Northwest Arkansas Chapter, 2018
PRESENTATIONS/SPEAKING ENGAGEMENTS/MEDIA/ADVOCACY
Transgender 101: The Basics, Lecture for PFLAG members, allies and families 4/1/19
Transgender Day of Visibility, Expert Panel Member for a Public Lecture and Q&A 3/30/19
Keynote Speaker: 6th Annual "The Bash" Benefiting Planned Parenthood Great Plains, Fayetteville, AR 3/14/19
Arkansas Democrat Gazette 10/18/18
https://www.arkansason line.com/news/2018/oct/15/d octors-praise-u-s-expansion-of-hpv-vac
ThinkProgress 8/7/18
https: thinkprogress.org trans patients -access -health -care -at -planned parenthood-arkansas-oklahoma-89d0720dddce/
KNWA 6/7/18
http://www.nwahomepgge.com/news/fox-24/cli n ics-want-mo re-education-after-man-admits-he-purposely_got-hiv/1225581123
Press Release and statement for Physicians for Reproductive Health 5/29/18
https_//prh.org/press-releases/arkansas-ban-creates-barriers-care/
Advocate 5/17/18
https://www.advocate.com/commentary/2018/5/17 part-idahotb-rec gnizing-we-alf-deserve-health-care
Transgender Day of Visibility, Expert Panel Member for a Public Lecture and Q&A 3/2018
Keynote Speaker: 5th Annual "The Bash" Benefiting Planned Parenthood Great Plains, Fayetteville, AR 9/28/17
Video -conference presentation on Planned Parenthood's work in Arkansas, in collaboration with Planned 9/27/17
Parenthood Federation of America, for a major donor interested in supporting existing services in the Little
Rock and Northwest Arkansas regions and funding new services in the Arkansas Delta region
Keynote Speaker: 4th Annual "The Bash" Benefiting Planned Parenthood Heartland, Fayetteville, AR 9/29/16
Keynote Speaker: 6th Annual Rally for Reproductive Justice, Arkansas State Capitol, Little Rock, AR 1/23/16
HERSHEL H. GARNER, JD,MD
Highlands Oncology Group
Curriculum Vitae
PERSONAL DATA
Date of Birth: 07/19/1953
Place of Birth: Little Rock, Arkansas
Citizenship: USA
Marital Status: Married
Home Address: 3390 E. Mission Boulevard
Fayetteville, AR 72704
EMPLOYMENT
Highlands Oncology Group, 06/02/2008 — Present
Correspondence Address My Service Address My Service Address
3232 N. North Hills Blvd. 808 South 52nd Street 60 E. Monte Painter Dr.
Fayetteville, AR 72703 Rogers, AR 72758 Fayetteville, AR 72703
(479) 587-1700 (479) 361-2585 (479) 361-2585
FAX: (479)587-1366 FAX: (479) 587-1366 FAX: (479) 571-1986
Northwest Arkansas Radiation Oncology Associates, for Northwest
Arkansas Radiation Therapy Institute (NARTI), 07/01/1990 — 06/01/08
PO Box 1955
Springdale, AR 72762
(479) 361-5847
FAX: (479) 361-9104
EDUCATION
College B.B.A. — Baylor University
Waco, TX
1975
Law School J.D. — University of Arkansas
Little Rock, AR
1980
Medical School M.D. — University of Arkansas College of Medicine
Little Rock, AR
08/01 /1981 — 05/17/1986
Hershel H. Garner, MD
Curriculum Vitae
Page 2
Internship University of Arkansas for Medical Sciences
Little Rock, AR
Specialty: Transitional
07/01 /1986 — 06/30/1987
Residency University of Louisville Program
Louisville, KY
Specialty: Radiation Oncology
07/01 /1987 — 06/30/1991
BOARD CERTIFICATIONS
Radiation Oncology -American Board of Radiology
Certification Date: 06/09/1994
LICENSURE
Arkansas, C-7086
Original Issue Date, 08/08/1986 — current
PROFESSIONAL ASSOCIATIONS
American Medical Association
Arkansas Medical Society
American Society for Therapeutic Radiology and Oncology
Washington County Medical Society
American College of Radiology
American College of Radiation Oncology
MEDICAL POSITIONS HELD
Ethics Committee Chairman, Washington Regional Medical Center
Ethics Committee Chairman, Northwest Medical Center
Circle of Life Hospice
IRB Chairman, Northwest Medical Center
Cancer Committee, Northwest Medical Center
Cancer Committee, Washington Regional Medical Center
Clinical Assistant Professor, University of Arkansas for Medical Sciences
State of Arkansas BreastCare Advisory Board
Chair Department of Radiation Oncology, UAMS